OBJECTIVE: Unmyelinated cutaneous axons are vulnerable to physical and metabolic injury, but also capable of rapid regeneration. This balance may help determine risk for peripheral neuropathy associated with diabetes or metabolic syndrome. Capsaicin application for 48 hours induces cutaneous fibers to die back into the dermis. Regrowth can be monitored by serial skin biopsies to determine intraepidermal nerve fiber density (IENFD). We used this capsaicin axotomy technique to examine the effects of exercise on cutaneous regenerative capacity in the setting of metabolic syndrome. METHODS: Baseline ankle IENFD and 30-day cutaneous regeneration after thigh capsaicin axotomy were compared for participants with type 2 diabetes (n = 35) or metabolic syndrome (n = 32) without symptoms or examination evidence of neuropathy. Thirty-six participants (17 with metabolic syndrome) then joined twice weekly observed exercise and lifestyle counseling. Axotomy regeneration was repeated in month 4 during this intervention. RESULTS: Baseline distal leg IENFD was significantly reduced for both metabolic syndrome and diabetic groups. With exercise, participants significantly improved exercise capacity and lower extremity power. Following exercise, 30-day reinnervation rate improved (0.051 ± 0.027 fibers/mm/day before vs 0.072 ± 0.030 after exercise, p = 0.002). Those who achieved improvement in more metabolic syndrome features experienced a greater degree of 30-day reinnervation (p < 0.012). INTERPRETATION: Metabolic syndrome was associated with reduced baseline IENFD and cutaneous regeneration capacity comparable to that seen in diabetes. Exercise-induced improvement in metabolic syndrome features increased cutaneous regenerative capacity. The results underscore the potential benefit to peripheral nerve function of a behavioral modification approach to metabolic improvement.
OBJECTIVE: Unmyelinated cutaneous axons are vulnerable to physical and metabolic injury, but also capable of rapid regeneration. This balance may help determine risk for peripheral neuropathy associated with diabetes or metabolic syndrome. Capsaicin application for 48 hours induces cutaneous fibers to die back into the dermis. Regrowth can be monitored by serial skin biopsies to determine intraepidermal nerve fiber density (IENFD). We used this capsaicin axotomy technique to examine the effects of exercise on cutaneous regenerative capacity in the setting of metabolic syndrome. METHODS: Baseline ankle IENFD and 30-day cutaneous regeneration after thigh capsaicin axotomy were compared for participants with type 2 diabetes (n = 35) or metabolic syndrome (n = 32) without symptoms or examination evidence of neuropathy. Thirty-six participants (17 with metabolic syndrome) then joined twice weekly observed exercise and lifestyle counseling. Axotomy regeneration was repeated in month 4 during this intervention. RESULTS: Baseline distal leg IENFD was significantly reduced for both metabolic syndrome and diabetic groups. With exercise, participants significantly improved exercise capacity and lower extremity power. Following exercise, 30-day reinnervation rate improved (0.051 ± 0.027 fibers/mm/day before vs 0.072 ± 0.030 after exercise, p = 0.002). Those who achieved improvement in more metabolic syndrome features experienced a greater degree of 30-day reinnervation (p < 0.012). INTERPRETATION:Metabolic syndrome was associated with reduced baseline IENFD and cutaneous regeneration capacity comparable to that seen in diabetes. Exercise-induced improvement in metabolic syndrome features increased cutaneous regenerative capacity. The results underscore the potential benefit to peripheral nerve function of a behavioral modification approach to metabolic improvement.
Authors: Eric P Davidson; Lawrence J Coppey; Nigel A Calcutt; Christine L Oltman; Mark A Yorek Journal: Diabetes Metab Res Rev Date: 2010-05 Impact factor: 4.876
Authors: Giuseppe Lauria; Mayienne Bakkers; Christoph Schmitz; Raffaella Lombardi; Paola Penza; Grazia Devigili; A Gordon Smith; Sung-Tsieh Hsieh; Svein I Mellgren; Thirugnanam Umapathi; Dan Ziegler; Catharina G Faber; Ingemar S J Merkies Journal: J Peripher Nerv Syst Date: 2010-09 Impact factor: 3.494
Authors: A Gordon Smith; James Russell; Eva L Feldman; Jonathan Goldstein; Amanda Peltier; Sheldon Smith; Jouhaina Hamwi; Donald Pollari; Billie Bixby; James Howard; J Robinson Singleton Journal: Diabetes Care Date: 2006-06 Impact factor: 19.112
Authors: Patricia M Kluding; Mamatha Pasnoor; Rupali Singh; Stephen Jernigan; Kevin Farmer; Jason Rucker; Neena K Sharma; Douglas E Wright Journal: J Diabetes Complications Date: 2012-06-18 Impact factor: 2.852
Authors: Pierre Watcho; Roman Stavniichuk; David M Ribnicky; Ilya Raskin; Irina G Obrosova Journal: Mediators Inflamm Date: 2010-04-08 Impact factor: 4.711
Authors: K Beriault; A C Carpentier; C Gagnon; J Ménard; J-P Baillargeon; J-L Ardilouze; M-F Langlois Journal: Int J Sports Med Date: 2009-07-07 Impact factor: 3.118
Authors: Patricia M Kluding; J Robinson Singleton; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; A Gordon Smith; Robin L Marcus Journal: Phys Ther Date: 2017-01-01
Authors: Ryan T Crews; Kristin L Schneider; Sai V Yalla; Neil D Reeves; Loretta Vileikyte Journal: Diabetes Metab Res Rev Date: 2016-06-10 Impact factor: 4.876